New Economic Modeling Shows Improved Lyme Disease Diagnostics Could Cut U.S. Lyme Healthcare Costs by 41.5%

ConferenceLyme Disease Diagnostic TestPositive

AI Analysis

Summary

Aces Diagnostics announced health economics analysis findings showing that a higher-sensitivity Lyme disease diagnostic test could reduce U.S. healthcare costs by 41.5% and misdiagnosis-related costs by 80%, with data to be presented at ADLM 2026.

Outcome Details

Data presentation at ADLM 2026 showing improved Lyme disease diagnostic test reduces U.S. healthcare costs by 41.5% and misdiagnosis-related costs by 80%

Importance:5/10

Sentiment:

0.70

diagnosticsLyme diseasehealth economicscost reductionconference presentationsensitivity improvement

Related Companies

$HR $HIT

Read the original article

Published by PR Newswire Biotech on July 23, 2026 12:39 PM

Read Original